TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Towards Healthcare
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

The global antitumor antibody-drug conjugate (ADC) drugs market is projected to grow from $8.33 billion in 2026 to $24.75 billion by 2035, driven by precision cancer therapies with reduced systemic toxicity and increasing cancer diagnoses worldwide.

Insights
RHHBY   positive

Continues expanding ADC portfolio with multiple ongoing clinical trials targeting various cancer types